Dean Michael Klisura, President and CEO of Marsh RE at Marsh & McLennan Companies, Inc., filed a Form 4 on October 26, 2026, disclosing the sale of common stock on October 23, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Dean Michael Klisura, President & CEO, Marsh RE
  • Transaction: Disposed of 4,194 shares of Common Stock on October 23, 2026
  • Sale price: $200 per share
  • Post-transaction ownership: 20,935.48 shares of Common Stock held directly
  • Rule 10b5-1 plan: The transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person
  • Exchange and ticker: NYSE:MRSH

Klisura's October 2026 Common Stock Sale Under 10b5-1 Plan

According to the filing, Dean Michael Klisura sold 4,194 shares of Marsh & McLennan Companies, Inc. Common Stock on October 23, 2026, at a price of $200 per share. The transaction is coded "S" in Table I of the Form 4, indicating a sale. The filing notes that Klisura holds the title of President & CEO, Marsh RE and is classified as an officer of the issuer.

The filing discloses that following the reported transaction, Klisura directly owns 20,935.48 shares of Common Stock. No indirect ownership or derivative securities are reported in the filing. The Form 4 was signed by Tessa Patti as attorney-in-fact and filed on October 26, 2026.

As noted in the filing's Explanation of Responses, "This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person." The filing also indicates, via a checked box, that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

What Was Disclosed

The Form 4 filed October 26, 2026, discloses a single sale of 4,194 shares of Marsh & McLennan Common Stock at $200 per share by officer Dean Michael Klisura on October 23, 2026, reducing his direct holdings to 20,935.48 shares.